Speaker illustration

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center & Parkland Health and Hospital S, Dallas (United States of America)

Member of:

European Society of Cardiology

Dr. Darren K. McGuire, MD, MHSc is Distinguished Teaching Professor of Internal Medicine at the University of Texas Southwestern Medical Center in the Division of Cardiology, where he holds the Dallas Heart Ball Chair for Research on Heart Disease in Women. Dr. McGuire is the Lead Physician of the Parkland Hospital and Health System Cardiology clinics. Dr. McGuire’s expertise is in large scale CV outcomes clinical trial design and execution, and drug registration/regulation, with a focus in the area of diabetes and cardiovascular disease. He presently has leadership roles for numerous international cardiovascular clinical outcomes trials, including T2DM, obesity, and lipid trials. Dr. McGuire is a previous member of the FDA Cardiovascular and Renal Drugs Advisory Committee and remains an FDA ad hoc consultant. He is Deputy Editor of Circulation, Senior Editor of Diabetes and Vascular Disease Research and co-editor of the textbook: Diabetes in Cardiovascular Disease: A Companion to Bra

A cross-specialty focus – Who are the appropriate patients for SGLT2is?

Event: ESC CONGRESS 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

Event: ESC CONGRESS 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

Five things cardiologists should know about diabetes

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium

Thumbnail

Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

This platform is supported by

logo Novo Nordisk